deployment of covid 19 vaccines
-
AstraZeneca Scientist Defends Plan to Start Selling COVID-19 Vaccine For Profit
A scientist who works on the AstraZeneca vaccine with Oxford University in the UK has come out to defend the decision to sell its COVID-19 vaccine at a profit, according to a new report from the Financial Times. AstraZeneca was previously unique because it sold the COVID-19 vaccine at cost, unlike most other vaccine makers…
-
U.S. President Joe Biden Will Reportedly Buy 500 Million Pfizer Vaccine Doses to Donate Globally
The U.S. Biden administration just struck a deal with Pfizer to buy 500 million doses of the covid-19 vaccine from the pharma giant, with plans to donate the doses to countries that need them, sources familiar with the pact told the Washington Post on Wednesday.
-
The AstraZeneca Vaccine Can’t Catch a Break
The covid-19 vaccine jointly developed by AstraZeneca and Oxford University is once again running into trouble. On Monday, Germany, France, and Italy became the latest countries to suspend their rollout of the vaccine over concerns that it may increase the risk of blood clots. However, many experts and regulators say these suspensions are unwarranted and…
